This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Credito, K. L.
Right arrow Articles by Appelbaum, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Credito, K. L.
Right arrow Articles by Appelbaum, P. C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2001, p. 67-72, Vol. 45, No. 1
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.1.67-72.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 Compared to Their Susceptibilities to 11 Other Agents

Kim L. Credito,1 Gengrong Lin,1 Glenn A. Pankuch,1 Saralee Bajaksouzian,2 Michael R. Jacobs,2 and Peter C. Appelbaum1,*

Department of Pathology, Hershey Medical Center, Hershey, Pennsylvania 17033,1 and Department of Pathology, Case Western Reserve University, Cleveland, Ohio 441062

Received 21 July 2000/Returned for modification 13 September 2000/Accepted 3 October 2000

The activity of the ketolide ABT-773 against Haemophilus and Moraxella was compared to those of 11 other agents. Against 210 Haemophilus influenzae strains (39.0% beta -lactamase positive), microbroth dilution tests showed that azithromycin and ABT-773 had the lowest MICs (0.5 to 4.0 and 1.0 to 8.0 µg/ml, respectively), followed by clarithromycin and roxithromycin (4.0 to >32.0 µg/ml). Of the beta -lactams, ceftriaxone had the lowest MICs (<= 0.004 to 0.016 µg/ml), followed by cefixime and cefpodoxime (0.008 to 0.125 and <= 0.125 to 0.25 µg/ml, respectively), amoxicillin-clavulanate (0.125 to 4.0 µg/ml), and cefuroxime (0.25 to 8.0 µg/ml). Amoxicillin was only active against beta -lactamase-negative strains, and cefprozil had the highest MICs of all oral cephalosporins tested (0.5 to >32.0 µg/ml). Against 50 Moraxella catarrhalis strains, all of the compounds except amoxicillin and cefprozil were active. Time-kill studies against 10 H. influenzae strains showed that ABT-773, at two times the MIC, was bactericidal against 9 of 10 strains, with 99% killing of all strains at the MIC after 24 h; at 12 h, ABT-773 gave 90% killing of all strains at two times the MIC. At 3 and 6 h, killing by ABT-773 was slower, with 99.9% killing of four strains at two times the MIC after 6 h. Similar results were found for azithromycin, with slightly slower killing by erythromycin, clarithromycin, and roxithromycin, especially at earlier times. beta -Lactams were bactericidal against 8 to 10 strains at two times the MIC after 24 h, with slower killing at earlier time periods. Most compounds gave good killing of five M. catarrhalis strains, with beta -lactams killing more rapidly than other drugs. ABT-773 and azithromycin gave the longest postantibiotic effects (PAEs) of the ketolide-macrolide-azalide group tested (4.4 to >8.0 h), followed by clarithromycin, erythromycin, and roxithromycin. beta -Lactam PAEs were similar and shorter than those of the ketolide-macrolide-azalide group for all strains tested.


* Corresponding author. Mailing address: Department of Pathology, Hershey Medical Center, P.O. Box 850, Hershey, PA 17033. Phone: (717) 531-5113. Fax: (717) 531-7953. E-mail: pappelbaum{at}psu.edu.


Antimicrobial Agents and Chemotherapy, January 2001, p. 67-72, Vol. 45, No. 1
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.1.67-72.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Bogdanovich, T., Smith, K. A., Clark, C., Pankuch, G. A., Lin, G., McGhee, P., Dewasse, B., Appelbaum, P. C. (2006). Activity of LBM415 Compared to Those of 11 Other Agents against Haemophilus Species.. Antimicrob. Agents Chemother. 50: 2323-2329 [Abstract] [Full Text]  
  • Bogdanovich, T., Clark, C., Ednie, L., Lin, G., Smith, K., Shapiro, S., Appelbaum, P. C. (2006). Activities of Ceftobiprole, a Novel Broad-Spectrum Cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.. Antimicrob. Agents Chemother. 50: 2050-2057 [Abstract] [Full Text]  
  • Kosowska, K., Credito, K., Pankuch, G. A., Hoellman, D., Lin, G., Clark, C., Dewasse, B., McGhee, P., Jacobs, M. R., Appelbaum, P. C. (2004). Activities of Two Novel Macrolides, GW 773546 and GW 708408, Compared with Those of Telithromycin, Erythromycin, Azithromycin, and Clarithromycin against Haemophilus influenzae. Antimicrob. Agents Chemother. 48: 4113-4119 [Abstract] [Full Text]  
  • Reinert, R. R. (2004). Clinical efficacy of ketolides in the treatment of respiratory tract infections. J Antimicrob Chemother 53: 918-927 [Abstract] [Full Text]  
  • Pankuch, G. A., Kelly, L. M., Lin, G., Bryskier, A., Couturier, C., Jacobs, M. R., Appelbaum, P. C. (2003). Activities of a New Oral Streptogramin, XRP 2868, Compared to Those of Other Agents against Streptococcus pneumoniae and Haemophilus Species. Antimicrob. Agents Chemother. 47: 3270-3274 [Abstract] [Full Text]  
  • Bozdogan, B., Clark, C., Bryskier, A., Jacobs, M. R., Appelbaum, P. C. (2003). Activities of HMR 3787 and RU 64399 Compared with Those of Four Other Agents against Haemophilus influenzae and Haemophilus parainfluenzae. Antimicrob. Agents Chemother. 47: 405-407 [Abstract] [Full Text]  
  • Neuhauser, M. M., Prause, J. L., Danziger, L. H., Pendland, S. L. (2001). Postantibiotic Effects of ABT-773 and Amoxicillin-Clavulanate against Streptococcus pneumoniae and Haemophilus influenzae. Antimicrob. Agents Chemother. 45: 3613-3615 [Abstract] [Full Text]